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Abstract
 
A particular feature of 
 

 
 T cell biology is that cells expressing T cell receptor (TCR) using
specific V
 

 
/V
 

 
 segments are localized in distinct epithelial sites, e.g., in mouse epidermis nearly
all 
 

 
 T cells express V
 

 
3/V
 

 
1. These cells, referred to as dendritic epidermal T cells (DETC)
 
originate from fetal V
 

 
3
 

 
 thymocytes. The role of 
 
 
 
TCR specificity in DETC’s migration/
localization to the skin has remained controversial. To address this issue we have generated
transgenic (Tg) mice expressing a TCR 
 

 
 chain (V
 

 
6.3-D
 

 
1-D
 

 
2-J
 

 
1-C
 

 
), which can pair
with V
 

 
3 in fetal thymocytes but is not normally expressed by DETC. In wild-type (wt)
V
 

 
6.3Tg mice DETC were present and virtually all of them express V
 

 
6.3. However, DETC
 
were absent in TCR-
 

 

 
/
 

 
 V
 

 
6.3Tg mice, despite the fact that V
 

 
6.3Tg 
 

 
 T cells were
present in normal numbers in other lymphoid and nonlymphoid tissues. In wt V
 

 
6.3Tg mice,
a high proportion of in-frame V
 

 
1 transcripts were found in DETC, suggesting that the ex-
pression of an endogenous TCR-
 

 
 (most probably V
 

 
1) was required for the development of
V
 

 
6.3
 

 
 epidermal 
 

 
 T cells. Collectively our data demonstrate that TCR specificity is essen-
tial for the development of 
 

 
 T cells in the epidermis. Moreover, they show that the TCR-
 

 
locus is not allelically excluded.
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Introduction
 

 
 T cells represent a small proportion of T cells in periph-
eral blood and lymphoid tissues, but they comprise the ma-
jority of T cells in certain epithelia, especially in those that
cover the internal and external surfaces of the body, such as
skin, reproductive tract, gastrointestinal tract, and lung.
While the majority of intestinal intraepithelial 
 

 
 T cells
arise independently from the thymus, it is generally ac-
cepted that 
 

 
 T cells develop from lymphoid precursors
that require the thymic microenvironment for their differ-
entiation. Compared with 
 

 
 T cells, however, little is
known with regard to the differentiation steps and selection
events that take place during intrathymic maturation of 
 

 
T cells. Moreover, the relationship between 
 

 
 and 
 

 
 T
cell precursors and the mechanisms underlying 
 

 
 versus 
 

 
T cell lineage commitment have not been clarified (1–4).
 
The analysis of the 
 

 
 TCR repertoire has demon-
strated an intriguing correlation between the usage of spe-
cific TCR V
 

 
/V
 

 
 combinations and the anatomical site
where these cells are found. This is particularly striking in
the epithelia of the skin and reproductive tract in the
mouse, where nearly all 
 

 
 T cells use V
 

 
3/V
 

 
1 and
V
 

 
4/V
 

 
1 receptors, respectively (5–7). In addition, most
human peripheral blood 
 

 
 T cells express V
 

 
9/V
 

 
2
TCR (8). This restricted TCR usage has suggested the ex-
istence of specific ligands for different 
 

 
 T cell subsets in
particular sites. However, neither the nature of these
ligands nor the mechanisms responsible for homing and/or
maintenance of different 
 

 
 T cell subsets in particular tis-
sues have been identified.
T cells in mouse epidermis are referred to as dendritic
 
epidermal T cells (DETC)
 
*
 
 because of their characteristic
cellular shape. Initially identified by the expression of
Thy-1 and CD3, these cells form a continuous network
among the basal layer of keratinocytes (9, 10). Although
little is known about the function of DETC, several stud-
 
Address correspondence to H. Robson MacDonald, Ludwig Institute for
Cancer Research, Lausanne Branch, University of Lausanne, CH-1066
Epalinges, Switzerland. Phone: 41-21-692-5989; Fax: 41-21-653-4474;
E-mail: hughrobson.macdonald@isrec.unil.ch
 
*
 
Abbreviations used in this paper: 
 
DETC, dendritic epidermal T cells; HS,
horse serum; iIEL, intestinal intraepithelial lymphocytes; RT, reverse
transcription; Tg, transgenic; wt, wild-type.
 1474
 
Role of T Cell Receptor in Epidermal 
 

 
 T Cell Development
 
ies indicate a biological relationship between DETC and
other epidermal cells. For example, activated DETC can
secrete keratinocyte growth factor and promote the
growth of epithelial cells in vitro, suggesting a role for
 
DETC in tissue repair (11, 12). In addition, it has been
reported that DETC can be activated by an unidentified
factor secreted by heat-stressed keratinocytes (5, 13–15).
Furthermore, their capacity to lyse in vitro different skin-
tumor cell lines (16) and to prevent in vivo tumor growth
has been demonstrated (17).
TCR sequence analysis of DETC clones generated from
different mouse strains has shown a very high TCR homo-
geneity, not only because all of them use a V
 

 
3J
 

 
1C
 

 
1/
V
 

 
1D
 

 
2J
 

 
2C
 

 
 TCR, but also because they lack junctional
diversity (5). This TCR homogeneity presumably con-
stricts DETC responses to a limited number of stimuli.
DETC originate from fetal thymocytes (18). Fetal thy-
mic 
 

 
 T cell differentiation is characterized by the sequen-
tial appearance of 
 

 
 T subsets with TCR composed of ca-
nonical 
 

 
 and 
 

 
 chains (19, 20). This is due to programmed
rearrangement of TCR 
 

 
 and 
 

 
 chains and the absence of
significant exonucleolytic nibbling or N nucleotide inser-
tions. The first thymic T cell population is detected around
day E14 and is composed almost exclusively of V
 

 
3/V
 

 
1
 

 
 T cells. These cells are considered to be DETC precur-
sors, which migrate to the skin. A second fetal thymic 
 

 
 T
cell subset expressing V
 

 
4/V
 

 
1 migrates to the epithelium
of the reproductive tract. The role of the 
 

 
 TCR in the
migration and/or localization of 
 

 
 T cell subsets to spe-
cific tissues has remained controversial. For example, Bon-
neville et al. found DETC expressing a transgenic (Tg) 
 

 
TCR (V
 

 
2/V
 

 
5) that is different from the normal DETC
 

 
 TCR (V
 

 
3/V
 

 
1; reference 21), and Iwashima et al.
found cells expressing a DETC Tg TCR (V
 

 
3/V
 

 
1) in tis-
sues other than the skin (22), suggesting that the migration
of 
 

 
 T cells to specific tissues may not be dictated by
TCR specificity. On the other hand, it has recently been
shown that DETC developing in either V
 

 
3- or V
 

 
1-defi-
cient mice express TCR with a very limited repertoire and
particular conformations, which emphasize the importance
of the TCR specificity in the localization of 
 

 
 T cells in
the skin (23, 24).
The recent analysis of TCR-
 

 
 rearrangements in hybrid-
 
omas derived from splenic 
 

 
 T cells has demonstrated
that TCR-
 

 
 gene expression is not subjected to allelic ex-
clusion (25). This possibility has not been considered pre-
viously when DETC development was examined in 
 

 
TCR Tg mice (21, 22). To reevaluate the role of the
TCR specificity in DETC development we have gener-
ated Tg mice expressing a TCR 
 

 
 chain (V
 

 
6.3-D1-
D2-J1-C) which can pair with V3 in the fetal thymus
but is not normally used by DETC. We show that DETC
expressing the Tg TCR  chain arise in wild-type (wt) Tg
mice, but fail to develop in the absence of endogenous
TCR- expression. These findings suggest that the speci-
ficity of the TCR is critical for the development of epider-
mal  T cells. Our results are discussed in the context of
TCR- allelic inclusion.
Materials and Methods
Mice. C57BL/6 (wt) and C57BL/6 TCR-/ (TCR-/)
mice were originally purchased from Harlan Netherlands and
The Jackson ImmunoResearch Laboratories, respectively. All
mice were used at 4–8 wk of age. Fetal mice were obtained from
timed matings where the day of finding a vaginal plug was desig-
nated as day 0 of embryonic development.
Generation of V6.3Tg Mice. A TCR- cDNA clone was iso-
lated from the RL6.14 hybridoma obtained from C57BL/6 DN
HSA thymocytes (26) using reverse transcriptase and the reverse
transcription (RT)-PCR. The forward primer (ATC GGT CGA
CGT CAC ATG CCT CCT CAC AGC containing a BamHI
site) and the reverse primer (ATC GGG ATC CCC GTA GTC
TCC TCA TGT CAG containing a SalI site) used in this reac-
tion are specific for the leader sequence of the V6 TCR seg-
ment and the C segment, respectively. DNA sequence determi-
nation of several independent clones revealed that this TCR 
chain is composed of V6.3 (ADV7S1), D1, D2, J1, and C
TCR segments, according to the V designation proposed by
Arden et al. (27). V6.3, which is the allele expressed in C57BL/6
mice, is recognized by mAb 8F4H7B7. This V6.3 cDNA was
inserted into the class I promoter expression cassette containing a
genomic fragment of the human  globin gene and the Ig heavy
chain enhancer element (see Fig. 3 A; reference 28). Subse-
quently, the Tg construct was excised from the vector and
microinjected into fertilized (C57BL/6  DBA.2)F2 eggs. Tg
founders were identified by PCR screening of genomic tail
DNA. The primers used were the forward primer 5	-GCC AAA
CCA TCT GTT TTC ATC-3	 (specific for the C segment)
and the reverse primer 5	-CTG GTG GGG TGA ATT CTT
TGC C-3	 (specific for the  globin exonIII). A single founder
was able to transmit the TCR- transgene to the progeny. This
male was backcrossed to C57BL/6 females to obtain V6.3Tg
mice expressing endogenous TCR- and to TCR-/ females
to obtain V6.3Tg mice lacking endogenous TCR- expression
(29). Data shown herein are derived from mice which have been
backcrossed at least four times.
Cell Preparations. Single-cell suspensions were prepared from
fetal thymi, adult liver, and spleen. The lymphocyte fraction in
the total liver cell suspension was recovered by centrifugation
(900 g for 20 min at room temperature), through a Percoll (Am-
ersham Pharmacia Biotech) gradient (total liver cells were resus-
pended in 8 ml 40% isotonic Percoll which was layered over 8 ml
80% isotonic Percoll). After harvesting the lymphocyte fraction at
the 40–80% interface, the cells were washed two times with PBS
containing 2% FCS before staining and flow cytometric analysis.
Epidermal Cell Suspensions. Epidermal cell suspensions were
prepared from ear skin after the protocol described by Schuler
and Steinman (30). Briefly, 8-wk-old mice were killed, the ears
were cut off, and mechanically split into dorsal and ventral sides,
then placed in 0.5% Trypsin (Life Technologies) in PBS contain-
ing 5% FCS. After a 30-min incubation at 37
C, the epidermis
was peeled off as a single sheet and epidermal cell suspensions
were obtained by filtering the trypsinized epidermal sheets
through a stainless-steel sieve. Subsequently, epidermal cell sus-
pensions were stained and analyzed by flow cytometry.
Isolation of Intestinal Intraepithelial Lymphocytes. Intestinal in-
traepithelial lymphocytes (iIEL) were isolated from individual
mice by standard methods (31) as detailed by Wilson et al. (32).
Briefly, mice were killed and the small intestines were removed
into cold PBS. Peyer’s patches were removed and the intestines
were then opened longitudinally, flushed with cold PBS to re-
move detritus, cut into small pieces, and washed twice in Ca2-
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and Mg2-free HBSS (Life Technologies) supplemented with 2%
horse serum (HS; Life Technologies). Intestinal pieces were incu-
bated two times in 50 ml HBSS/1mM Hepes/1 mM DTT/2.5
mM NaHCO3/10% HS for 20 min at 37
C with constant stirring
in a bottle precoated with HS to minimize cell loss by adhesion.
Cells released into the supernatant were harvested by filtration
through a stainless-steel sieve and washed once in HBSS/Hepes/
5% HS. The lymphocyte fraction was subsequently recovered by
centrifugation at 900 g for 15 min through a Percoll gradient (5
ml 44% isotonic Percoll layered over 5 ml 67.5% isotonic Percoll)
at room temperature. After harvesting the lymphocyte fraction at
the 44–67.5% interface the cells were washed twice in HBSS/5%
HS before analysis.
Antibodies. The following mAb conjugates were used: anti–
CD3-PE (clone 17A2), anti–TCR-–FITC (clone GL3), anti-
Thy-1–FITC or Cy5 (clone AT15), anti-V1.1–FITC (clone
2.11), anti-V2–FITC (clone UC3–10A6), anti-V3–FITC or
biotinylated (clone F536), anti-V4–FITC or –PE (clone GL2),
anti-V5–FITC or –PE (clone 45.152), anti-V6.3–FITC or –PE
(clone 8F4H7B7), anti-B220–APC (clone RA3.6B2), anti-TCR-
–APC (clone H57), anti-TCR--Cy5 (GL3), anti-F4/80–Cy5
(clone F4/80), anti-CD45.2–Cy5 (clone 104), and anti-CD24–
FITC (clone M1/69). Anti-Thy-1–FITC and -Cy5, anti–TCR-
-Cy5, anti-F4/80–Cy5, anti-V1.1–FITC, anti-V2–FITC,
anti-V4–FITC and -PE, and anti-V5–FITC and -PE antibodies
were purified and conjugated in this laboratory; 2.11 and 45.152
clones (33) were provided by P. Pereira (Institut Pasteur, Paris,
France). Anti-CD45.2-Cy5 was conjugated in this laboratory
from protein purchased from BD PharMingen. The rest of the
mAb conjugates were purchased from BD PharMingen.
Flow Cytometry and Sorting. Cells were preincubated with
2.4G2 culture supernatant to block Fc receptors, then washed
and incubated with the indicated mAb conjugates for 30 min at
4
C in a final volume of 100 l PBS containing 2% FCS. Cells
were washed and analyzed on a FACSCalibur™ flow cytometer
using CELLQuest™ software (Becton Dickinson). Dead cells
were gated out by their forward and side scatter profile. Elec-
tronic sorting of adult thymic  T cells and of fetal thymic V3
V6.3 cells (populations A and B) was performed on a FAC-
Star™ flow cytometer (Becton Dickinson).
RT-PCR, Cloning, and Sequencing of V1. Total RNA was
extracted from 106 epidermal cells with TRIzol reagent (Life
Technologies) according to the manufacturer’s instructions. The
first-strand cDNA from extracted RNA was synthesized with
oligo(dT) (Amersham Pharmacia Biotech) in a final volume of
20 l using AMV reverse transcriptase. PCR was performed in a
final volume of 50 l containing 1 l cDNA, MgCl2 (1.5 mM),
PCR buffer (1), V1 and C primers (1 M each), dNTPs
mixture (0.2 mM each), and 1 U of cloned Pfu DNA polymerase
(Stratagene). Each of the 35 cycles consisted of 1 min at 94
C, 1
min at 60
C, and then 1 min at 72
C. Before the first cycle, a
2-min 94
C denaturation step was included, and after the 35th
cycle the extension at 72
C was prolonged for 5 min. PCR for
-actin was performed (using the same PCR conditions) as control.
The sequence of the oligonucleotides used as primers for the
PCR are as follows: V1 forward primer, 5	-GGA ATT CAG
AAG GCA ACA AT-3	; C reverse primer, 5	-GGA ACC
GTA GTC TCC TCA TG-3	; -actin forward primer, 5	-GTG
GGC CGC TCT AGG CAC CAA-3	; -actin reverse primer
5	-CTC TTT GAT GTC AGC CAC GAT TTC-3	. After pu-
rification (StrataPrep; Stratagene) PCR products were cloned
into the PCR-Script™ Amp Cloning Kit (Stratagene). Clones
were sequenced on both strands in a LI-COR 4200L automatic
sequencer (Lincoln) using the Excell II Sequitherm kit (Inotech).
Sequences were aligned using Sequencher software (GeneCodes
Corporation).
RT-PCR Primers for TCR- Expression. In addition to the
forward V1 primer and reverse C primer mentioned above,
the following forward primers were used: V4 primer, 5	-CCG
CTT CTG TGT GAA CTT CC-3	; V5 primer, 5	-CAG ATC
CTT CCA GTT CAT CC-3	; and V6 primer, 5	-TCA AGT
CCA TCA GCC TTG TC-3	.
Results
TCR V and V Usage of DETC. We have taken ad-
vantage of newly available mAbs against different V and
V TCR segments to further characterize DETC TCR di-
versity in wt mice using flow cytometry. DETC were
identified among epidermal cells by the expression of
CD45.2 and CD3. A CD45.2 CD3 population repre-
sents 2–3% of the total epidermal cell suspension in adult
mice (Fig. 1). Most cells expressing CD45.2 but not CD3
(2% of the total epidermal suspension) express MHC class
II molecules (data not shown) and represent the other ma-
jor compartment of bone marrow–derived cells in the skin:
the Langerhans cells. DETC are Thy-1 and express V3,
as described previously, but do not express V1.1 or V2
TCR segments (Fig. 1). In addition, DETC do not express
any of the TCR V segments preferentially used by thymic
and splenic  T cells in adult mice (V4, V5, or V6.3),
consistent with previous data demonstrating that V3 pref-
erentially pairs with V1 in DETC clones (5). As shown in
Fig. 1, CD3 cells are not detected in epidermal suspen-
sions from TCR-/ mice, which demonstrates that the
normal DETC population depends on a  TCR.
TCR V Usage of V3  T Cells in the Fetal Thymus.
It has been demonstrated that DETC originate from an
early wave of lymphoid precursors that colonize the fetal
thymus (18), which are characterized by the exclusive rear-
rangement and expression of V3. To determine whether
the TCR homogeneity found in DETC is shared by puta-
tive DETC precursors we have analyzed the TCR V us-
age of fetal V3 thymocytes by flow cytometric analysis at
different stages of embryonic development. For that pur-
pose, thymi of wt fetuses were analyzed at different days of
embryonic development. The results are summarized in
Fig. 2.  T cells were identified in the Thy1 fraction of
fetal thymocytes. In agreement with previous results (19)
V3  T cells are detected as early as E14 and E15 (data
not shown), but they constitute a very small population at
these stages. For that reason, we have analyzed the TCR
V usage of V3 thymocytes at E16, E17, and E18, when
V3 thymocytes are particularly abundant. A clear popu-
lation of  T cells representing 6% of Thy1 thy-
mocytes can be identified at these embryonic stages (data
not shown). As indicated in Fig. 2, the percentage of V3
 T cells progressively decreases as embryonic develop-
ment progresses (62% at E16, 42.5% at E17, and 24% at
E18), becoming nearly undetectable by the first week after
birth (data not shown) consistent with earlier data (19, 34).
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V6.3, V5, or V4 expressing thymocytes can first be de-
tected on E16. As shown in Fig. 2, in contrast to V3, the
percentages of V6.3, V5, or V4 expressing thymocytes
increase throughout embryonic development. Interest-
ingly, between E16 and E18, V3 pairs to a significant ex-
tent with V6.3 and V5, but not with V4. These results
demonstrate that a large proportion of fetal thymic V3
 T cells in normal mice use TCR V segments other
than V1 (such as V5 and V6.3), which is in sharp con-
trast to what is observed in the skin (Fig. 1). This raises the
possibility that intrathymic selection and/or selective mi-
gration of  T cells from the fetal thymus to the skin, pre-
vents the development of V3V6.3 or V3V5
DETC in normal mice.
V6.3 Tg Mice. Based on the finding that among fe-
tal thymic  T cells V3 pairs with TCR V segments
other than V1 (for example V6.3), we have generated
V6.3Tg mice in order to study the role of  TCR speci-
ficity in DETC development. A mouse TCR cDNA
clone composed of V6.3, D1, D2, J1, and C gene
segments was isolated from the RL6.14 hybridoma derived
from C57BL/6 DN HSA thymocytes (26) and inserted
into the class I promoter/Ig enhancer expression cassette
(28) (Fig. 3 A). This promoter drives the expression of the
Figure 1. TCR V and V usage
of DETC. Epidermal cell suspen-
sions were prepared from wt and
TCR-/ mice. The cells were an-
alyzed after three color staining with
anti-CD45.2 (Cy5 conjugate), anti-
CD3 (PE conjugate), and FITC-
conjugated mAbs specific for differ-
ent T cell markers. DETC were
identified as CD45.2 CD3 epi-
dermal cells as indicated in the dot
plots. The percentage of DETC and
the percentage of the remaining
bone marrow–derived (CD45.2)
epidermal cells in the total epidermal
suspension are indicated. Histograms
show the expression of Thy-1,
TCR, V, and V TCR segments
by DETC. The percentage of
DETC positive for each one of these
markers is indicated. These data are
representative of three independent
experiments with similar results.
Figure 2. TCR V usage of
V3 thymocytes during fetal
thymic development. Thy-
mocyte suspensions were ob-
tained from wt C57BL/6 em-
bryos at the indicated day of
gestation. Four color staining
was performed with anti-CD3
(CyChrome conjugated), a
cocktail of APC/Cy5-conju-
gated mAbs (including anti–
TCR-, anti-B220, anti-F4/80,
and anti-Gr1), anti-V3 (FITC
conjugate), and the indicated
anti-V (PE conjugate). Coex-
pression of V3 and each of the
Vs by E16, E17, or E18 thymic
 T cells was analyzed by gating
on CD3 APC/Cy5 cocktail
thymocytes. Numbers indicate
the percentage of cells in the re-
spective quadrants. The data are
representative of two indepen-
dent analyses with similar results.
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V6.3 transgene as early as E15 of fetal thymic develop-
ment in both TCR-/ V6.3Tg embryos (Fig. 3 B) and
wt V6.3Tg embryos (data not shown), before detectable
endogenous V6.3 expression (Fig. 3 C).
Expression of the V6.3 Transgene during Fetal Thymic De-
velopment. To assess whether the V6.3 transgene is ex-
pressed at the protein level by V3 putative DETC pre-
cursors early in fetal ontogeny, timed pregnant females
from wt V6.3Tg crosses were killed at E16-E18. Embryos
were typed and fetal thymi were analyzed individually. A
population of  T cells (3–5% of the total fetal thy-
mocytes) was observed in all wt embryos (data not shown).
In V6.3Tg embryos 60–80% of the thymic  T cells ex-
pressed V6.3 on E16-E18 as compared with 5–7% in non-
Tg littermates (Fig. 4). Thus a considerable proportion
(20–40%) of thymic  T cells in wt V6.3Tg mice is
V6.3, suggesting that V6.3 transgene expression does
not efficiently suppress endogenous TCR in early fetal
thymic  T cells. A large population (40–50%) of wt
V6.3Tg fetal thymocytes coexpressed V3 and V6.3
demonstrating that the V6.3 transgene can pair with V3
as early as E16 (Fig. 4).
Similarly, timed pregnancies were set up with TCR-/
V6.3Tg mice. A population of  T cells was detected as
early as E16 in the thymus of TCR-/ V6.3Tg em-
bryos but not in TCR-/ non-Tg littermate controls
(Fig. 4 and data not shown). As expected, in the absence of
endogenous TCR-, all fetal thymic  T cells were
V6.3 in the Tg embryos. Importantly, a large fraction of
V6.3 fetal thymocytes (50–70%) paired with V3 (Fig.
4). These results demonstrate that the V6.3 transgene is
expressed by V3 putative fetal thymic DETC precursors
as early as E16 in the presence or absence of endogenous
TCR- expression.
Interestingly, we noted two distinct populations coex-
pressing V3 and V6.3 at different levels (populations A
and B in Fig. 4) in wt V6.3Tg embryos. Further analysis
of these two populations will be presented below.
Role of the TCR in the Development of Epidermal  T
Cells. To examine whether fetal  T cells that do not
express the canonical V3/V1 TCR can give rise to
DETC we analyzed DETC from V6.3Tg mice. In con-
trast to what is found in wt non-Tg mice, virtually all
DETC from wt V6.3Tg mice express V6.3 and V3
(Fig. 5). Additionally, DETC in these mice do not express
V5, V4, V1.1, or V2 TCR segments (data not
shown). These results indicate that Tg fetal thymic
V3V6.3  T cells have migrated to the skin. How-
ever, when we analyzed epidermal preparations from
TCR-/ V6.3Tg mice, no DETC were found (Fig. 5).
Figure 3. (A) DNA construct for V6.3Tg mice. The detailed DNA construction is described in Materials and Methods. A mouse TCR6.3 cDNA
clone was isolated from the RL6.14 hybridoma (from C57BL/6 DN thymocytes) and inserted into the class I promoter/Ig enhancer expression cassette.
(B) Expression of V6.3 transgene at an early stage of fetal thymic T cell development. E15 embryos were obtained from TCR-/ V6.3Tg crosses.
Each littermate was typed (data not shown) and analyzed individually. RNA was extracted from total thymocytes and RT-PCR was performed using
V6.3 transgene specific primers (C primer and -globin primer in A, as forward and reverse primers, respectively). -actin RT-PCR was performed in
parallel as a positive control. A 550-bp band specific for V6.3 transgene expression was detected in the thymus of E15 TCR/ V6.3Tg embryos but
not in control (non-Tg) embryos. (C) Expression of endogenous VC transcripts in wt adult thymic  T cells and wt E15 thymocytes. Wt E15 thy-
mocytes were obtained from timed pregnant females. Adult thymic  T cells were obtained by electronic sorting after CD4/CD8 complement deple-
tion. RNA was extracted and RT-PCR was performed using specific primers for the indicated V-C transcripts. -actin RT-PCR was performed in
parallel as a positive control.
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These results show that the V6.3 transgene is not able to
promote the development of DETC. They suggest rather
that the migration and/or localization of fetal  T cells
to the skin in wt V6.3Tg mice is dependent on an en-
dogenous TCR-. It is likely that this endogenous TCR-
uses V1, the expression of which has been demonstrated
to be restricted to fetal thymocytes and DETC (5, 18). As
there are no mAbs against V1, we have tested this hy-
pothesis by RT-PCR, cloning and sequencing of V1-
C DETC transcripts. As shown in Fig. 6 A, a V1-C
PCR product was observed using cDNA templates pre-
pared from epidermal cells of both V6.3Tg and non-Tg
mice. In contrast, no product was detected in epidermal
cells from TCR-/ mice (Fig. 6 A). To determine
whether the V1-C PCR product corresponded to in-
frame TCR  chains, multiple independent clones were
sequenced (Fig. 6 B). Indeed, 17 out of 20 clones (85%)
analyzed were in-frame, with 82% of them having the
published canonical sequence for V1-C (5, 35, 36).
These findings indicate that DETC present in wt
V6.3Tg mice express V1 in addition to the V6.3
transgene. Therefore, it is likely that the endogenous V1
is responsible for the development of V6.3 DETC in
wt V6.3Tg mice, which would imply that fetal thymic
Figure 4. Analysis of V6.3
transgene expression by fetal
thymic DETC precursors. E16-
E18 fetuses were obtained from
wt V6.3Tg or TCR/
V6.3Tg crosses. Embryos were
typed and analyzed individually.
The dot plot corresponding to
E16 TCR/ V6.3Tg thy-
mocytes shows the V3 versus
V6.3 expression of Thy-1
CD3 thymocytes analyzed after
four color staining using anti-
Thy1 (APC conjugate), anti-
CD3 (CyChrome conjugate),
anti-V3 (FITC conjugate), and
anti-V6.3 (PE conjugate). For
the rest of the cases, four color
staining was performed on thy-
mocyte suspensions using anti-
CD3 (CyChrome conjugate), an
APC/Cy5-conjugated mAb
cocktail (described in Fig. 2 leg-
end), anti-V3 (FITC conju-
gate), and anti-V6.3 (PE conjugate).  T cells, identified as CD3 APC/Cy5 cocktail thymocytes, were analyzed for V3 and V6.3 expression.
Data shown here are representative of individual fetal thymi. In two separate experiments, two or more fetuses of each type (Tg or non-Tg) were ana-
lyzed yielding similar results.
Figure 5. The development of
epidermal  T cells is depen-
dent upon TCR specificity. Epi-
dermal cell suspensions obtained
from V6.3Tg and non-Tg mice
on either wt or TCR-/
backgrounds, were three color
stained using anti-CD45.2 (Cy5
conjugate), anti-CD3 (PE conju-
gate), and either anti-V3 or
anti-V6.3 (FITC conjugates).
The percentage of DETC
(CD45 CD3 cells) in the total
epidermal suspension from each
mouse is indicated. Histograms
show V3 or V6.3 expression
by DETC. Left and right panels
correspond to analyses per-
formed on wt and TCR-/
backgrounds respectively. Data
shown are representative of three
independent experiments with
identical results.
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DETC precursors express two TCR  chains on the same
cell in these mice.
V6.3Tg  T Cells Are Present in other Lymphoid and
Nonlymphoid Tissues. To exclude the possibility that
V6.3 transgene expression prevented the emigration of 
T cells from the thymus, we analyzed  T cell popula-
tions in various anatomical sites. As shown in Fig. 7 A,
V6.3  T cells in wt non-Tg mice represent 17, 20,
and 33% of total  T cells in iIEL, liver, and spleen, re-
spectively. When we analyzed TCR-/ V6.3Tg mice,
in contrast to the skin, we were able to find normal num-
bers of  T cells in the iIEL, spleen, and liver (Fig. 7 B).
As expected, all of these  T cells were V6.3 due to the
absence of endogenous TCR- expression. These results
show that V6.3Tg  T cells can migrate to and reconsti-
tute organs other than the skin. Therefore, the failure to
reconstitute DETC in TCR-/ V6.3Tg mice is not
due to an impediment to migration of the Tg  T cells,
but rather to the lack of expression of a permissive TCR,
most probably V3/V1.
Role of TCR Specificity in Intrathymic Maturation of Putative
DETC Precursors. A likely candidate for V6.3 DETC
precursors in wt V6.3Tg mice could be V3 fetal thy-
mocytes included in population B (Fig. 4), as this popula-
tion is absent in TCR-/V6.3Tg mice (Fig. 4) which
also lack DETC (Fig. 5). Population B was already promi-
nent as early as E16 (Fig. 4). Since this population was se-
lectively absent in TCR-/ V6.3Tg embryos (Fig. 4) it
seemed likely that it may correspond to V3V6.3 cells
expressing endogenous TCR  chains. Cells in population
B did not express surface V4 or V5 (data not shown),
thus raising the interesting possibility that they might ex-
press the canonical V3/V1 TCR. This hypothesis was
directly tested by sorting populations A and B from E18 wt
V6.3Tg thymi and analyzing V1-C transcripts by semi-
quantitative RT-PCR. As shown in Fig. 8 A population B
contained 10-fold higher levels of V1-C transcripts
than population A consistent with expression of a V3/
V1 TCR in addition to the V3/V6.3 TCR detected by
surface staining.
Previous studies (37) have shown that the maturation of
fetal V3 thymocytes in normal mice is accompanied by
upregulation of TCR expression and concomitant down-
regulation of CD24 (HSA). Since population B expressed
higher levels of V3 than population A, we also analyzed
these subsets for expression of CD24. As shown in Fig. 8 B
Figure 6. Analysis of V1 ex-
pression by V6.3 Tg DETC. (A)
RT-PCR for V1-C tran-
scripts in DETC. RNA was ex-
tracted from epidermal cell sus-
pensions of the indicated mice,
and RT-PCR was performed us-
ing specific primers for V1-C
transcripts (see Materials and
Methods). -actin was used as
an amplification control. (B)
V1-C junctions of 20 inde-
pendent PCR clones derived
from epidermal cells from wt
V6.3Tg mice were sequenced
and compared with the pub-
lished canonical sequence (refer-
ence 5). 17 clones had in-frame
V1-C sequences, 14 of which
matched the canonical DETC
TCR. Three clones lacked part
of the V1 segment as well as
the D and J regions. These
may represent aberrantly spliced
V1-C transcripts.
1480 Role of T Cell Receptor in Epidermal  T Cell Development
population B showed significant CD24 downregulation as
compared with population A.
Collectively, these data raise the intriguing possibility
that the intrathymic maturation of V3/V1 DETC pre-
cursors involves selection events based on TCR specificity.
Discussion
Since they were first identified, mouse DETC have
been considered a homogeneous population of T cells ex-
pressing V1/V3 TCR (5, 6). TCR sequence analysis
and the generation of a mAb against V3 has demon-
strated that the expression of V3 bearing TCR is re-
stricted to the epidermis and to fetal thymocytes (5, 6).
These results, together with the finding that repopulation
of DETC in adult mice is only possible upon transplanta-
tion of both fetal lymphoid precursors and fetal thymus
(38), have led to the assumption that fetal V3 thy-
mocytes are DETC precursors. We have examined
whether the TCR homogeneity found in DETC, is a con-
sequence of a restricted  TCR pattern of expression by
putative fetal thymic DETC precursors. We found, as pre-
viously shown by other authors (19), that V3 cells are
the predominant T cell subset at early stages of fetal in-
trathymic T cell differentiation (E15–17). Interestingly,
as early as E16 we found V3 paired with both V5 and
V6.3, but not with V4 (despite the fact that this chain is
already expressed at these stages), showing that V3 can
pair with Vs other than V1. These results clearly dem-
onstrate that the TCR diversity of putative intrathymic
DETC precursors is much greater than that observed in
DETC in the skin thereby raising the possibility that only
fetal thymic  T cells expressing an appropriate TCR will
localize later in the epidermis.
We further investigated the importance of  TCR
specificity for DETC migration/localization in the skin by
generating a new TCR- Tg mouse. For this purpose we
chose a TCR  chain containing the V6.3 segment be-
cause this segment can pair with V3 in putative DETC
Figure 7. V6.3 Tg  T cells
can reconstitute the  T cell
compartment in the intestinal
epithelium, liver, and spleen.
iIEL were stained with anti-
CD45.2 (Cy5 conjugate), anti-
TCR (FITC conjugate), and
anti-V6.3 (PE conjugate). iIEL
contour plots show the TCR-
versus V6.3 expression pattern
after gating on CD45.2 cells.
Spleen and liver cell suspensions
were stained using anti-CD3
(PE conjugate), anti-V6.3
(FITC conjugate), and a cocktail
including anti–TCR-, anti-
B220, anti-F4/80, and anti-Gr1
mAbs (APC or Cy5 conju-
gates). Spleen and liver contour
plots correspond to CD3 versus
V6.3 expression after gating out
APC-cocktail cells. Numbers
indicate percentage of cells in
the respective quadrant.
Figure 8. Characterization of two
populations of V3 V6.3 fetal
thymocytes in wt V6.3Tg mice.
(A) Thymocytes in populations A or
B (see Fig. 4) were isolated by elec-
tronic sorting from E18 wt V6.3Tg
fetuses. RNA was extracted from
equal numbers of cells and semi-
quantitative RT-PCR was per-
formed using primers specific for
V1-C transcripts (see Material and
Methods). RT-PCR for -actin and
for the V6.3 transgene (C-
globin) were included as controls. (B) Four color staining was performed
in thymocytes from E18 wt V6.3Tg embryos using in a first step anti-
CD3 (CyChrome conjugate), anti-V3 (biotin conjugate), anti-V6.3
(PE conjugate), and anti-CD24 (FITC conjugate), followed by a second
step with streptavidin-APC. Overlapping histograms correspond to CD24
levels of V3 V6.3 thymocytes in population A (gray profile) or in
population B (empty profile).
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precursors of wt mice. Our results demonstrate that fetal
thymocytes indeed express the V6.3 transgene in associa-
tion with V3 as early as E15-E16 on both wt and TCR-
/ backgrounds. As expected, all thymic  T cells
expressed V6.3 in TCR-/ V6.3Tg embryos. Inter-
estingly, only 75% of thymic  T cells expressed V6.3
on the cell surface in wt V6.3Tg embryos, suggesting that
a considerable fraction of  T cells expressed endogenous
TCR  chains (see below).
DETC from V6.3Tg mice were analyzed in order to
examine whether enforced V6.3 expression on putative
DETC precursors would affect their development. In wt
V6.3Tg mice we found a normal percentage of DETC in
the epidermis. Interestingly, virtually all DETC from these
mice express V3 and V6.3 segments, in contrast to non-
Tg littermates. But surprisingly no CD3 cells are found in
epidermal cell suspensions from TCR-/ V6.3Tg
mice. The fact that V6.3Tg  T cells reconstitute the 
T cell compartment in the iIEL, liver, and spleen of TCR-
/ V6.3Tg mice, demonstrates that the absence of
DETC is not because of a general deficiency in migration
of the V6.3Tg  T cells, but rather to the lack of expres-
sion of a TCR that is permissive for skin localization.
These results strongly suggest that a  TCR, in which an
endogenous TCR  chain takes part, has directed the mi-
gration and/or localization of DETC to the epidermis of
wt V6.3Tg mice. As V1 is most frequently associated
with V3 in DETC (5), we investigated whether V1 was
expressed in wt V6.3Tg DETC. Indeed, PCR and se-
quence analysis showed a large proportion (85%), of in-
frame V1 transcripts, most of which corresponded to the
canonical V1 DETC sequence (5). Therefore, we can
conclude that wt V6.3Tg DETC express a second TCR-,
most probably V1, and that the expression of this sec-
ond TCR- is a prerequisite for their development. The
expression of two different TCR  chains by the same cell
can also be inferred from the analysis of V3 and V6.3
expression in wt V6.3Tg embryos. There, cells expressing
both V3 and V6.3 are distributed into two different
populations. One population (A in Fig. 4) presumably cor-
responds to cells expressing exclusively V3/V6.3 TCR
as suggested by its presence in TCR-/ V6.3 Tg mice.
In contrast, population B (which is absent in TCR-/
V6.3Tg embryos), would correspond to cells expressing
two different types of  TCR: one of them V3/V6.3,
and the other V3 paired with V1. We believe that ex-
pression of this second  TCR is a prerequisite for DETC
maturation and/or localization in the skin. In wt non-Tg
embryos, population B represents only 0.3%, which could
explain the fact that V6.3 DETC are not detected in
normal mice. Taken together our results provide strong
evidence for the simultaneous expression of two different
TCR  chains at the cell surface of primary  T cells, thus
confirming and extending the concept of allelic inclusion
of the TCR  locus as proposed initially for  T cell hy-
bridomas by Sleckman et al. (25).
Collectively, our results strongly suggest that TCR
specificity is critical for fetal  T cells to migrate/localize
in the skin. This conclusion is in apparent disagreement
with an earlier study by Bonneville et al. (21) who investi-
gated DETC migration in V2/V5 double Tg mice.
They found that most DETC expressed this Tg  TCR
and, as they did not consider the expression of endogenous
TCR  and TCR  chains, they concluded that TCR
specificity was not essential for the normal migration of 
T cells to the epidermis. These authors rather proposed
that intrinsic properties of DETC precursors were respon-
sible for migration to the skin. However, if that were the
case, we should have found V3/V6.3 DETC in TCR-
/ V6.3Tg mice.
Recently, mice deficient for either V3 or V1 expres-
sion have been reported (23, 24). In both types of mice it is
possible to observe DETC expressing TCR other than the
prototypic V3/V1. However, in V3/ mice DETC
preferentially expressed V1-bearing TCR which were
recognized in large proportion by the mAb 17D1. Since
this mAb was originally described as recognizing a confor-
mational epitope found exclusively in V3/V1 DETC
(39), the authors speculated that a limited number of TCR
conformations are permissive for DETC development. In-
terestingly in V1/ mice, relatively normal numbers of
DETC developed and the most frequently used TCR 
chain was V6. However, in contrast to the Tg TCR 
chain used in our study (V6.3-D1-D2-J1-C) most of
the V6 chains in DETC of V1/ mice lacked D1 and
had relatively few nucleotide additions in the CDR3 re-
gion, suggestive of a fetal thymic origin. Thus, the failure
of our Tg V6.3 chain to support DETC development
(even though it is paired with V3 in the fetal thymus) may
reflect the absence of an (as yet unidentified) critical CDR3
motif that allows the migration and/or localization of
DETC in the skin. Alternatively it is possible that most (or
all) V3/V6 TCR are able to support DETC develop-
ment, but only very inefficiently. According to this sce-
nario, the presence of polyclonal V6 populations in V1/
mice would collectively allow relatively efficient DETC
generation, whereas monoclonal V6.3 T cells present in
TCR-/ V6.3Tg mice would not be able to generate
detectable numbers of DETC.
In conclusion, our data, as well as those obtained from
V3- and V1-deficient mice, support the concept of an
important role for the  TCR in DETC development.
Several possibilities could be envisaged to explain these re-
sults. First, an intrathymic process could positively select
only  T cells with a particular TCR specificity, which
would subsequently migrate to the skin independently of
this specificity. Migration in this case could be directed by
the expression of homing receptors as has been shown for
Langerhans cell migration to the skin in humans (40, 41).
This interesting hypothesis is further supported by our
finding that two populations of V3V6.3 thymocytes
can be defined at E16-E18 in wt V6.3Tg mice. Whereas
population A does not express endogenous V1 and has a
TCRlo CD24hi phenotype, population B expresses endoge-
nous V1 and is TCRhi CD24lo. Since TCRhi CD24lo
V3 thymocytes represent the mature progeny of TCRlo
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CD24hi V3 precursors in normal mice (37) our data raise
the intriguing possibility that population B has matured as a
result of selection by specific “DETC selecting ligands” in
the fetal thymus and thus that  T cells may pass through
an intrathymic selection process as  T cells do. Alterna-
tively, it cannot be excluded that TCR specificity could by
itself direct the migration of  T cells to the skin or that
 T cells expressing diverse TCR specificities could mi-
grate to the skin, but only those having a permissive TCR
would be retained and/or locally expand, perhaps due to
the recognition of a ligand expressed specifically by kerati-
nocytes in the skin. Future experiments will be required to
distinguish between these possibilities.
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